Atlas Trials

A Study in Patients With Fabry Disease Who Are on Chronic Hemodialysis Therapy for Treatment of End-stage Renal Insufficiency.

Clinical trial NCT00312767 · WITHDRAWN

Trial details

NCT number
NCT00312767
Sponsor
Genzyme, a Sanofi Company
Status
WITHDRAWN
Phase
Phase 4
Study type
INTERVENTIONAL
Fabry Disease
Start date
2006-04-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.